USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/25898
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEldhose, Wilson
dc.date.accessioned2023-10-28T12:50:28Z
dc.date.accessioned2023-11-01T05:06:43Z
dc.date.available2023-10-28T12:50:28Z
dc.date.available2023-11-01T05:06:43Z
dc.date.issued2023
dc.identifier.citationELDHOSE, Wilson. Medication used in cerebrovascular accidents at the prehospital stage. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2023, vol. 10(3), anexa 1, p. 452. ISSN 2345-1467.en_US
dc.identifier.issn2345-1467
dc.identifier.urihttps://conferinta.usmf.md/wp-content/uploads/Culegerea-Rezumate-MJHS_10_3_2023_anexa1.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/25898
dc.descriptionUniversitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica Moldovaen_US
dc.description.abstractBackground. The management of cerebrovascular accidents, which include conditions like ischemic strokes and hemorrhagic strokes, is highly dependent on prehospital care. Certain drugs are frequently given to patients in the prehospital situation to stabilize them and prevent more brain damage. Objective of the study. The objective is to provide an overview of the medications administered to patients in the prehospital stage of cerebrovascular accidents. Material and methods. For the completion of the goal, investigations were carried out using a variety of sources, such as electronic libraries like PubMed Central, PubMed, and NIH, on papers that were published between 2012 and 2023. Results. According to the investigation, anticoagulants like heparin and warfarin, as well as antiplatelet agents (aspirin and clopidogrel), have been recommended for usage in cerebrovascular accidents. The most frequent age range for stroke presentations was 61–80 years, followed by 41–60 years (47% and 46%, respectively). Hemorrhage-related strokes were more uncommon (60%) than those with ischemic strokes. There were more male patients than female ones. The study group included individuals with alcoholism, smoking, hypertension, diabetes, anemia, and proteinuria. Conclusions. During this critical period, medicines have a major role in minimizing the severity and progression of strokes, thus, it is crucial to take into account the unique patient characteristics, medical history, and contraindications. In order to improve patient outcomes and lessen the burden of stroke-related disability, comprehensive stroke care must include the administration of suitable drugs in cerebrovascular accidents during the prehospital stage.en_US
dc.languageen
dc.publisherInstituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldovaen_US
dc.relation.ispartofRevista de Științe ale Sănătății din Moldova: Moldovan Journal of Health Sciences: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 18-20 octombrie 2023, Chișinău, Republica Moldovaen_US
dc.subjectcerebrovascular accidentsen_US
dc.subjectstrokeen_US
dc.subjectblood pressureen_US
dc.titleMedication used in cerebrovascular accidents at the prehospital stageen_US
dc.typeOtheren_US
Appears in Collections:Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2023 nr. 3(10) Anexa 1

Files in This Item:
File Description SizeFormat 
MJHS_10_3_2023_anexa1_452.pdf149.11 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback